Summary
Erythrocyte aldose reductase was determined in 90 NIDDM patients by a two-site ELISA using recombinant human aldose reductase. The level of aldose reductase did not correlate with age, duration of diabetes, fasting blood glucose and HbA1cof the patients. Among 38 patients with diabetes for more than 10 years, aldose reductase in those with retinopathy (including non-proliferative and proliferative) was significantly higher than in those without, while no difference in the means of the average HbA1c, maximum and minimum blood pressure levels was observed between the two groups. The results indicate that the level of aldose reductase in the erythrocyte of diabetic patients is associated with the presence of retinopathy.
Article PDF
Similar content being viewed by others
Abbreviations
- NIDDM:
-
Non-insulin-dependent diabetes mellitus
- IDDM:
-
insulin-dependent diabetes mellitus
References
Greene DA, Lattimer SA (1984) Action of sorbinil in diabetic peripheral nerve: relationship of polyol (sorbitol) pathway inhibition to a myo-inositol-mediated defect in sodium potassium ATPase activity. Diabetes 33: 712–716
Nishimura C, Lou MF, Kinoshita JH (1987) Depletion of myo-inositol and amino acids in galactosemic neuropathy. J Neurochem 49: 290–295
Robison WG Jr, Kador PF, Kinoshita JH (1983) Retinal capillaries: basement membrane thickening by galactosemia prevented with aldose reductase inhibitor. Science 221: 1177–1179
Engerman RL, Kern TS (1984) Experimental galactosemia produces diabetic-like retinopathy. Diabetes 33: 97–100
Kinoshita JH, Nishimura C (1988) The involvement of aldose reductase in diabetic complications. Diabetes Metab Rev 4: 323–337
Nishimura C, Yamaoka T, Mizutani M, Yamashita K, Akera T, Tanimoto T (1991) Purification and characterization of the recombinant human aldose reductase expressed in baculovirus system. Biochim Biophys Acta 1078: 171–178
Nishimura C, Furue M, Ito T, Omori Y, Tanimoto T (1993) Quantitative determination of human aldose reductase by enzyme-linked immunosorbent assay. Biochem Pharmacol 46: 21–28
Van Kampen EJ, Zijlstra WG (1961) Standardization of hemoglobinometry. II. The hemoglobincyanide method. Clin Chim Acta 6: 538–544
Crabbe MJC, Peckar CO, Halder AB, Cheng H (1980) Erythrocyte glyceraldehyde-reductase levels in diabetics with retinopathy and cataract. Lancet II: 1268–1270
Hamada Y, Kitoh R, Raskin P (1993) Association of erythrocyte aldose reductase activity with diabetic complications in type 1 diabetes mellitus. Diabetic Med 10: 33–38
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nishimura, C., Saito, T., Ito, T. et al. High levels of erythrocyte aldose reductase and diabetic retinopathy in NIDDM patients. Diabetologia 37, 328–330 (1994). https://doi.org/10.1007/BF00398062
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00398062